A twist too many for Asmanex
Executive Summary
Dosage counter on Schering-Plough's Asmanex Twisthaler (mometasone furoate) may incorrectly display a number of doses remaining after the drug supply is exhausted, Institute for Safe Medication Practices' Medication Safety Alert reports Nov. 16. Although product labeling states that "the inhaler will not deliver subsequent doses once the counter reaches zero," Schering is aware that "if a patient 'forcefully' attempts to remove the cap once the dosage counter reaches '00,' the counter could reset" to display 199 doses, ISMP states...
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.